The future of hepatobiliary cancer surgery
- Prof.Dr. Ünal Aydın

- Sep 19, 2025
- 4 min read
Hepatobiliary cancers are a group of malignancies that develop in the components of the hepatobiliary system, including the liver, gallbladder, bile ducts, and pancreas. These cancers often do not show symptoms in their early stages and are frequently diagnosed late. Therefore, if left untreated, hepatobiliary cancers can have high mortality rates. Hepatobiliary cancer surgery plays a crucial role in the treatment of these diseases, but the future of surgery is continuously evolving with technological advancements, innovative treatment methods, and multidisciplinary approaches. This article will discuss the current status and future potential developments of hepatobiliary cancer surgery.
Definition of Hepatobiliary Cancers and the Role of Surgery
Hepatobiliary cancers range from primary liver cancer, known as hepatocellular carcinoma (HCC), to bile duct cancers (cholangiocarcinoma). These types of cancers are often associated with excessive alcohol consumption, hepatitis B and C infections, gallstone diseases, genetic factors, and environmental factors.
Surgical treatment for hepatobiliary cancers is determined by a number of factors, such as the stage of the cancer and the patient's overall health. For patients diagnosed in the early stages, surgical intervention is one of the most effective options for successful cancer treatment. However, surgical treatment can be a very challenging process because these cancers are often diagnosed at a late stage. In this article, we will focus on how the future of hepatobiliary cancer surgery will be shaped and which developments will be important.
Current Status of Hepatobiliary Cancer Surgery
Hepatobiliary cancer surgery includes a range of conventional and innovative approaches. The main goal of these surgeries is to completely remove the cancerous tissue as much as possible. The primary surgical treatment methods used for hepatobiliary cancers are:
Hepatic Resection (Liver Resection) Hepatic resection is the fundamental surgical approach for treating liver cancer. The removal of cancerous liver tissue is performed to preserve healthy liver tissue. This procedure involves removing a portion of the liver and is generally applied when the patient's liver function is sufficient. However, if too much of the liver is removed, a careful evaluation is necessary to ensure the remaining liver can maintain adequate function.
Bile Duct Surgery Surgical intervention for bile duct cancers involves removing the cancerous area and clearing the diseased bile ducts. Bile duct cancer is known as cholangiocarcinoma, and the treatment process depends on the extent of cancer spread and which part of the bile duct is affected.
Liver Transplantation Liver transplantation is an important part of surgery and can be an option, especially for liver cancer patients in cases where the liver needs to be completely removed. Liver transplantation is performed only when the cancer has not spread outside the liver and the patient's overall health is good. This treatment can be life-saving, especially for patients with cirrhosis and a cancerous liver.
Pancreatic Cancer Surgery Pancreatic cancer is one of the most challenging hepatobiliary cancers to treat. For cancers that develop in the head of the pancreas, a surgical method known as the Whipple procedure is applied. In this operation, the head of the pancreas, the gallbladder, the duodenum, and some blood vessels are removed.
The Future of Hepatobiliary Cancer Surgery
The future of hepatobiliary cancer surgery will be shaped by genetic research, personalized treatment approaches, and technological innovations. Here are some key factors that could shape the future of hepatobiliary cancer surgery:
Minimally Invasive Surgical Methods Minimally invasive surgical techniques allow patients to recover faster, have shorter hospital stays, and experience less pain. Laparoscopic surgery and robotic surgery are increasingly preferred in hepatobiliary cancer surgery. These techniques allow surgeons to reach the depths of the liver more precisely, cause less tissue damage, and accelerate the recovery process.
Robotic surgery allows surgeons to move more precisely with a three-dimensional view and perform more complex procedures safely. In hepatobiliary cancers, robotic surgery offers a great advantage, especially in the surgical removal of large tumors and deeply located cancers.
Genetic and Molecular Testing Genetic testing can help to better understand hepatobiliary cancers. Understanding the genetic basis of cancer can provide information on which treatment options will be more effective. For example, some hepatobiliary cancers may have specific genetic mutations, and these mutations can affect the response to treatment. Genetic testing also plays a critical role in predicting treatment response and personalizing the treatment process.
Molecular biology marks a new era in cancer staging and shaping treatment processes. Advanced biomarkers and genomic analyses are very important in guiding treatment before and after surgery.
Immunotherapy and Targeted Therapies Immunotherapy is emerging as an important step in cancer treatment. Immunotherapy methods are increasingly being used in the treatment of hepatobiliary cancers. Treatment methods such as PD-1 and PD-L1 inhibitors, in particular, allow cancer cells to be recognized by the immune system and help the body destroy cancer more effectively.
Targeted therapies provide treatment by focusing on specific molecular targets of cancer cells. In hepatobiliary cancers, targeted therapies are used before or after surgery to prevent cancer from recurring.
Fetal Cell Therapy and Stem Cells Fetal cell therapy and stem cell research could offer a potential future treatment option for hepatobiliary cancer treatment. The potential for stem cells to repair or replace cancerous liver tissue could be used as a complementary treatment method to surgery.
Artificial Intelligence and Surgical Robots Artificial intelligence (AI) and surgical robots could make hepatobiliary cancer surgery more precise in the future. AI can help surgeons make decisions faster and more accurately. Artificial intelligence could make it possible to make earlier diagnoses with imaging techniques, predict patients' responses to treatment, and optimize the results of surgery.
Conclusion
Hepatobiliary cancer surgery is a rapidly developing field, and innovations in this area will shape the future success of surgery. Innovations such as minimally invasive surgical techniques, genetic testing, immunotherapy, and targeted therapies will make the patient's treatment process more effective and ensure better results from surgery. In addition, the increased use of artificial intelligence and surgical robots will enable surgeons to perform treatments more precisely and effectively.
The future of surgery in hepatobiliary cancer treatment requires a multidisciplinary approach. This points to a future where surgeons, oncologists, geneticists, and researchers work in collaboration. Thanks to technological innovations, personalized treatment methods, and early diagnosis, it will be possible to achieve more successful results in the treatment of hepatobiliary cancers.


Comments